AHC
IBB icon

Anderson Hoagland & Co’s iShares Biotechnology ETF IBB Stock Holding History

Anderson Hoagland & Co’s Portfolio IBB Stock Details IBB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$3.24M Buy
17,022
+2,384
+16% +$410K 0.25% 87
2026
Q1 		$2.47M Sell
14,638
-3,000
-17% -$513K 0.21% 94
2025
Q4 		$2.98M Buy
+17,638
New +$2.86M 0.26% 87

Other funds holding IBB

Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
Citigroup
Citigroup New York $303B AUM 53.02% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
BNP Paribas Financial Markets
BNP Paribas Financial Markets Paris, France $289B AUM 60.46% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
Envestnet Asset Management
Envestnet Asset Management Chicago, Illinois $424B AUM 22.96% 1-Year Est. Return
Raymond James Financial
Raymond James Financial St Petersburg, Florida $369B AUM 28.27% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return
CB
Commerce Bank Kansas City, Missouri $22.8B AUM 28.56% 1-Year Est. Return

Anderson Hoagland & Co's IBB Position: Q2 2026 in Review

Anderson Hoagland & Co increased its iShares Biotechnology ETF (IBB) stake by 16% in Q2 2026, buying an estimated $410K and bringing the position to 17,022 shares worth $3.24M. The position accounts for 0.25% of the portfolio, ranked #87.

Anderson Hoagland & Co first reported a position in IBB in Q4 2025 and has held it in 3 quarters since. 954 funds tracked by Wall St. Rank hold IBB as of Q2 2026.

  • Anderson Hoagland & Co held 17,022 shares of iShares Biotechnology ETF worth $3.24M as of Q2 2026.
  • Anderson Hoagland & Co bought 2,384 iShares Biotechnology ETF shares in Q2 2026, an estimated $410K.
  • iShares Biotechnology ETF made up 0.25% of Anderson Hoagland & Co's portfolio in Q2 2026, its #87 holding.
  • Anderson Hoagland & Co first reported a position in iShares Biotechnology ETF in Q4 2025 and has held it in 3 quarters since.
  • 954 funds tracked by Wall St. Rank held iShares Biotechnology ETF as of Q2 2026.

Based on Anderson Hoagland & Co's 13F filing for Q2 2026, filed 6 Jul 2026.